Movement Alert｜Medtronic PLC Intraday Rise 3.06% in Regular Trading, prior earnings beat and product approvals remained supportive

Market Focus10-22

On October 22, Medtronic PLC rose 3.06% in Regular Trading, trading at $95.88 per share, with turnover of $216 million.

The most relevant publicly available backdrop was a recent analyst update in which BTIG trimmed its price target to $99 from $100 while the broader analyst stance remained constructive, with a mean target around $103.52. That target change was modest and did not alter the overall positive view.

Supporting fundamentals came from the company’s September quarter update, when Medtronic PLC reported adjusted EPS of $1.45 on revenue of $9.76 billion, both above expectations, and raised fiscal guidance to $5.94 to $6.00. More recently, the company also disclosed regulatory milestones for its Affera Prism-2 mapping software and PulseSelect ProxBox Adapter, as well as FDA clearance for the LigaSure RAS Maryland device used with the Hugo robotic-assisted surgery system.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment